Renaud, Jean-Paul, 1960-
Jean-Paul Renaud researcher
Renaud, Jean-Paul, 19..-....
Renaud, Jean-Paul
VIAF ID: 49284653 (Personal)
Permalink: http://viaf.org/viaf/49284653
Preferred Forms
- 100 0 _ ‡a Jean-Paul Renaud ‡c researcher
-
- 100 1 _ ‡a Renaud, Jean-Paul
- 100 1 _ ‡a Renaud, Jean-Paul ‡d 1960-
- 100 1 _ ‡a Renaud, Jean-Paul, ‡d 19..-....
- 100 1 _ ‡a Renaud, Jean-Paul, ‡d 1960-
4xx's: Alternate Name Forms (1)
5xx's: Related Names (2)
- 511 2 _ ‡a Laboratoire de génie de la conception (Strasbourg)
- 511 2 _ ‡a Université de Strasbourg (2009-....)
Works
Title | Sources |
---|---|
3,5-T2 is an alternative ligand for the thyroid hormone receptor β1. | |
Amphioxus postembryonic development reveals the homology of chordate metamorphosis. | |
Application of new crystallization approaches and serial crystallography to the structural study of enzyme/tRNA complexes. | |
Biophysics in drug discovery: impact, challenges and opportunities. | |
Characterization of novel checkpoint kinase 1 inhibitors by in vitro assays and in human cancer cells treated with topoisomerase inhibitors. | |
Cisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP. | |
Conformational heterogeneity of cytochrome P450 3A4 revealed by high pressure spectroscopy. | |
Cryo-EM in drug discovery: achievements, limitations and prospects | |
Développement et validation du logiciel S4MPLE : application au docking moléculaire et à l'optimisation de fragments assistée par ordinateur dans le cadre du fragment-based drug design | |
Effect of the distal residues on the vibrational modes of the Fe-CO bond in hemoglobin studied by protein engineering | |
High affinity of ergopeptides for cytochromes P450 3A. Importance of their peptide moiety for P450 recognition and hydroxylation of bromocriptine | |
In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE. | |
International Union of Pharmacology. LXVI. Orphan nuclear receptors | |
Knockout mice for the metabotropic glutamate receptor mGluR7 reveal its role in cognition and emotions. | |
Mass spectrometry and ion mobility developments to the study of supramolecular biological complexes. | |
One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit Lists | |
Oxydations d'alcanes et d'alcènes par des systèmes métalloporphyriniques modèles du cytochrome P-450 | |
Particular ability of liver P450s3A to catalyze the oxidation of N omega-hydroxyarginine to citrulline and nitrogen oxides and occurrence in no synthases of a sequence very similar to the heme-binding sequence in P450s | |
Purification of the human RARgamma ligand-binding domain and crystallization of its complex with all-trans retinoic acid. | |
Recombinant yeast in drug metabolism. | |
Retinoic acid receptor: a simulation analysis of retinoic acid binding and the resulting conformational changes | |
Stereochemistry of carbon monoxide binding to normal human adult and Cowtown haemoglobins | |
Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni | |
Structural biology in drug discovery : methods, techniques, and practices | |
Structural genomic approach to study Schislosoma mansoni nuclear receptors. | |
Structure, fonction et inhibition du ribosome de Candida albicans | |
Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains | |
Structure-function analysis reveals the molecular determinants of the impaired biological function of DAX-1 mutants in AHC patients | |
Thermodynamic studies of substrate binding and spin transitions in human cytochrome P-450 3A4 expressed in yeast microsomes. | |
X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation. |